Moriroku Company, Ltd.

4249.T
Specialty Chemicals
2026/08/06 Updated
Market Cap: $233.5M (¥36.8B)
Stock Price: $16.31 (¥2,573)
Exchange Rate: 1 USD = ¥157.73

FY2027 First Quarter Cash Summary

Disclosure of the first quarter results for FY2027. Net sales are about 338.21 billion yen, up about 42.5% YoY; operating income about 6.07 billion yen; net income for the period about 0.906 billion yen. Segment-wise improvements suggest gains aided by currency effects.

Importance:
Page Updated: August 6, 2026
IR Disclosure Date: August 6, 2026

Key Figures

  • Net Sales: 33,821百万円
  • Operating Income: 6,028百万円
  • Net Income: 1,861百万円

AI要約

Section Heading

This results summary for the first quarter of FY2027 shows a substantial year-on-year increase in net sales, with continued growth by segment. Key figures include net sales of 33,821 million yen, operating income of 60,728 million yen, and net income for the period of 1,861 million yen. While considering currency effects and notes, quarterly growth drivers may include the consolidated impact of the ReNova business and price adjustments.

Section 2 Heading

Detailed data by segment and location is provided, showing the breakdown of sales by Japan, North America, Asia, etc., and each segment's contribution to profit. For the full-year outlook, disclosures are within the notes accompanying this material, with the focus on how the consolidated effect of the ReNova business acquired in April 2026 will affect the full year.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Moriroku Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →